A Phase I/IB Study of OSI-906 and Irinotecan in Patients With Advanced Cancer With Expanded Cohorts of Patients With Colorectal Cancer Stratified by the OSI-906 Integrated Classifier
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2013
At a glance
- Drugs Linsitinib (Primary) ; Irinotecan
- Indications Cancer; Colorectal cancer
- Focus Adverse reactions; Pharmacokinetics; Registrational; Therapeutic Use
- 18 Oct 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jan 2013 Planned End Date changed from 1 Dec 2011 to 1 Dec 2015 as reported by ClinicalTrials.gov.